BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 21883853)

  • 21. New immunophenotype of circulating endothelial progenitor cells and endothelial microparticles in patients with erectile dysfunction and metabolic syndrome: effects of tadalafil administration.
    La Vignera S
    Int Angiol; 2011 Oct; 30(5):415-23. PubMed ID: 21804479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of on-demand tadalafil for the treatment of erectile dysfunction in South-East Asian men.
    Guo YL; Zhu JC; Pan TM; Ding Q; Wang YX; Cheong NF; Lim E; Shen W; Venugopalan M; Chan M
    Int J Urol; 2006 Jun; 13(6):721-7. PubMed ID: 16834650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study.
    Hatzichristou D; Haro JM; Martin-Morales A; von Keitz A; Riley A; Bertsch J; Belger M; Wolka AM; Beardsworth A;
    Int J Clin Pract; 2007 Nov; 61(11):1850-62. PubMed ID: 17850306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Porst H; Giuliano F; Glina S; Ralph D; Casabé AR; Elion-Mboussa A; Shen W; Whitaker JS
    Eur Urol; 2006 Aug; 50(2):351-9. PubMed ID: 16766116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Losartan improves erectile dysfunction in diabetic patients: a clinical trial.
    Chen Y; Cui S; Lin H; Xu Z; Zhu W; Shi L; Yang R; Wang R; Dai Y
    Int J Impot Res; 2012; 24(6):217-20. PubMed ID: 22931760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Testosterone Solution 2% on Ejaculatory Dysfunction in Hypogonadal Men.
    Maggi M; Heiselman D; Knorr J; Iyengar S; Paduch DA; Donatucci CF
    J Sex Med; 2016 Aug; 13(8):1220-6. PubMed ID: 27436077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation of four-item version of Male Sexual Health Questionnaire to assess ejaculatory dysfunction.
    Rosen RC; Catania JA; Althof SE; Pollack LM; O'Leary M; Seftel AD; Coon DW
    Urology; 2007 May; 69(5):805-9. PubMed ID: 17482908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect on sexual function of a vacuum erection device post-prostatectomy.
    Engel JD
    Can J Urol; 2011 Jun; 18(3):5721-5. PubMed ID: 21703048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy and safety of tadalafil: an update.
    Carson CC; Rajfer J; Eardley I; Carrier S; Denne JS; Walker DJ; Shen W; Cordell WH
    BJU Int; 2004 Jun; 93(9):1276-81. PubMed ID: 15180622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time from dosing to sexual intercourse attempts in men taking tadalafil in clinical trials.
    Shabsigh R; Burnett AL; Eardley I; Sharlip ID; Ellsworth PI; Garcia CS; Natanegara F; Ahuja S
    BJU Int; 2005 Oct; 96(6):857-63. PubMed ID: 16153217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tadalafil for treatment of erectile dysfunction in men on antidepressants.
    Segraves RT; Lee J; Stevenson R; Walker DJ; Wang WC; Dickson RA
    J Clin Psychopharmacol; 2007 Feb; 27(1):62-6. PubMed ID: 17224715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sexual function and satisfaction in heterosexual couples when men are administered sildenafil citrate (Viagra) for erectile dysfunction: a multicentre, randomised, double-blind, placebo-controlled trial.
    Heiman JR; Talley DR; Bailen JL; Oskin TA; Rosenberg SJ; Pace CR; Creanga DL; Bavendam T
    BJOG; 2007 Apr; 114(4):437-47. PubMed ID: 17284249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of sexual dysfunction with lower urinary tract symptoms of BPH and BPH medical therapies: results from the BPH Registry.
    Rosen RC; Wei JT; Althof SE; Seftel AD; Miner M; Perelman MA;
    Urology; 2009 Mar; 73(3):562-6. PubMed ID: 19167031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Rosen RC; Fitzpatrick JM;
    BJU Int; 2009 Oct; 104(7):974-83. PubMed ID: 19426189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction.
    Hatzichristou D; Gambla M; Rubio-Aurioles E; Buvat J; Brock GB; Spera G; Rose L; Lording D; Liang S
    Diabet Med; 2008 Feb; 25(2):138-46. PubMed ID: 18290855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erectile dysfunction in systemic sclerosis: effects of longterm inhibition of phosphodiesterase type-5 on erectile function and plasma endothelin-1 levels.
    Proietti M; Aversa A; Letizia C; Rossi C; Menghi G; Bruzziches R; Merla A; Spera G; Salsano F
    J Rheumatol; 2007 Aug; 34(8):1712-7. PubMed ID: 17611982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials.
    Blonde L
    Curr Med Res Opin; 2006 Nov; 22(11):2111-20. PubMed ID: 17076971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sexual dysfunctions and blood hormonal profile in men with focal epilepsy.
    Kuba R; Pohanka M; Zákopcan J; Novotná I; Rektor I
    Epilepsia; 2006 Dec; 47(12):2135-40. PubMed ID: 17201714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 6-month study of the efficacy and safety of tadalafil in the treatment of erectile dysfunction: a randomised, double-blind, parallel-group, placebo-controlled study in Australian men.
    McMahon CG; Stuckey BG; Lording DW; Wittert GA; Murphy A; Shin J; Sutherland PD; Palmer NR; Lowy MP; Jesudason DR; Fredlund P
    Int J Clin Pract; 2005 Feb; 59(2):143-9. PubMed ID: 15854188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of alfuzosin 10 mg once daily on sexual function in men treated for symptomatic benign prostatic hyperplasia.
    Rosen R; Seftel A; Roehrborn CG
    Int J Impot Res; 2007; 19(5):480-5. PubMed ID: 17717526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.